If your biopharmaceutical project needs strong R&D funding, SynergiQc is an important program in Quebec. It supports collaborative research between Quebec companies and public research institutions, with funding of up to $1.5 million per project. The program is selective, and the application process expects a clear business and research plan from the beginning.
Below is a guide on how to apply for the SynergiQc program for biopharmaceutical research, who qualifies, and what funders look for.
SynergiQc is delivered by the Quebec Consortium for Drug Discovery (CQDM). It funds projects that advance biopharmaceutical and life sciences innovations with real industrial potential.
To apply, your project must meet all of the following conditions:
SynergiQc does not fund companies working alone. Find a research partner before applying.
SynergiQc offers non-dilutive funding, which means you do not need to give up ownership or equity in your company. However, it does not cover all project costs.
Your budget must clearly show how the remaining costs will be covered by company and institutional contributions.
Understanding the timeline and review process can help you plan your application and set realistic expectations.
Stay aware of deadlines and review periods for better project and partner coordination.
Applying for the SynergiQc program for biopharmaceutical research is a structured process. Strong coordination between partners is critical.
Before writing anything, confirm that:
Tools like GrantHub’s eligibility matcher can help you filter programs by province and industry quickly, which is helpful if SynergiQc is one of several funding options you’re considering.
CQDM prioritizes projects with a clear industrial application. Your proposal must explain:
Your application must show real collaboration:
Weak or unbalanced partnerships are a common reason for rejection.
Your budget should:
Applications are submitted directly to CQDM. Timelines and calls for projects are published on the CQDM website. Late or incomplete applications are not reviewed.
Treating the company as a passive partner
CQDM expects active industrial involvement, not just a symbolic collaboration.
Misjudging TRL levels
Projects outside TRL 1–6 are ineligible, even if the science is strong.
Underestimating budget scrutiny
Vague or inflated costs weaken credibility and can reduce your funding.
Ignoring Quebec impact
Economic and scientific benefits for Quebec must be clear and direct.
Q: Who is eligible to apply for the SynergiQc program?
Public research institutions in Quebec working closely with at least one eligible Quebec-based company can apply.
Q: What types of projects does SynergiQc fund?
SynergiQc funds collaborative biopharmaceutical and life sciences research projects with clear industrial applications.
Q: How much funding can a SynergiQc project receive?
Projects can receive up to $1.5 million, covering a maximum of 40% of total project costs, usually over three years.
Q: Does funding differ for SMEs and large enterprises?
Yes. The maximum assistance rate varies depending on whether the industry partner is an SME or a large enterprise.
Q: Is SynergiQc funding taxable?
SynergiQc funding is generally considered government assistance and may affect tax credits such as SR&ED. SR&ED is a federal tax credit program for R&D in Canada. Tax treatment can vary, so it is recommended to consult a tax professional for advice specific to your situation.
SynergiQc is a good choice if your biopharmaceutical research is collaborative, Quebec-based, and industry-driven. GrantHub tracks hundreds of active grant programs across Canada, including specialized Quebec R&D funding—making it easier to see how SynergiQc fits into your broader funding strategy and what other programs may complement it.
Was this article helpful?
Rate it so we can improve our content.
Canada Proactive Disclosure Data
The Canadian government has funded over 400,000 businesses through 1.27 million grants and contributions. Check your eligibility in 60 seconds.